THE FDA advisory committee have met to discuss the new drug application (NDA) for Bayer’s rivaroxaban.
25/03/2009
The US Advisory Committee on Immunization Practices (ACIP) has released provisional recommendations for Human Papillomavirus vaccinations.
04/12/2009
AUSTRALIA’S oral health status has ranked second worst in the OECD Community Services and Health Industries face skills crisis in oral health.
30/07/2009
QUEENSLAND Health’s Patient Safety and Quality Executive Committee has been awarded internationally recognised ISO 9001 Standard for Quality Management
20/07/2009
VISIONCARE Ophthalmic Technologies has announced the FDA Ophthalmic Devices Advisory Panel unanimously recommended the FDA approve, with conditions, the premarket application (PMA) for its implantable telescope for End-Stage age-related macular degeneration (AMD).
01/04/2009
THE AUSTRALIAN Government has released an expert committee’s evaluation of the BreastScreen Australia program and has said the valuable program will continue.
09/09/2009
INDIGENOUS affairs proponent Chicka Dixon has taken out the Outstanding Achievement in Aboriginal and Torres Strait Islander Health at the prestigious Deadly Awards on 15 October.
16/10/2009
NOVARTIS has been granted Marketing Authorisation by theEuropean Commission for its Ixiaro Vaccine developed for the prevention of Japanese Encephalitis (JE).
06/04/2009
CORGENIX says it will exhibit its AspirinWorks Test at the XXII Congress and the ISTH 2009 conference held from 11 to 16 July.
13/07/2009
NSW Chief Health Officer encourages H1N1 vaccination
People are encouraged to have the Pandemic (H1N1) 2009 influenza vaccination, states NSW Chief Health Officer Kerry Chant.
06/11/2009
NOVARTIS has received a positive opinion supporting European Union (EU) approval of Glivec (imatinib) as a post-surgery treatment for patients at significant risk of relapse following removal of gastrointestinal stromal tumours (GIST).
24/03/2009
The Therapeutic Goods Administration (TGA) has approved for registration the Australian-made Panvax H1N1 Vaccine Junior enabling children from 6 months to 9 years of age to be protected against the pandemic H1N1 influenza.
04/12/2009
WESTERN Australian researchers have been awarded nearly two million dollars in research grants under a project aimed at increasing efficiencies, cost savings and improving patient outcomes across the State’s health system.
24/08/2009
The Strategic Advisory Group of Experts (SAGE) on Immunization, which advises WHO on policies and strategies for vaccines and immunization, met in Geneva last week to discuss policies and strategies for the pandemic (H1N1) vaccine. The experts also made recommendations on the formulation of seasonal influenza vaccines for the southern hemisphere in 2010.
02/11/2009
Applications for the Federal Government’s AUD$560 million Regional Cancer Centres are now open. Eligible public or private organisations can apply for infrastructure funding to establish new or enhanced regional cancer centres.
17/11/2009
Screening and surveillance guidelines for the for the early detection of colorectal cancer and adenomatous polyps have been released by the US Agency for Healthcare Research and Quality (AHRQ).
08/12/2009
THE THERAPEUTIC Goods Administration (TGA) has approved the world’s first intradermal (ID) influenza vaccine, Intanza, for the prevention of seasonal influenza in adults and the elderly
02/04/2009
The Australian Government has allocated a share of $108m to 15 medical research teams across the country.
10/02/2009
As at 31 December 2009, of the 6 million doses of Panvax distributed in Australia, there were 1289 suspected side effects reported to the Therapeutic Goods Administration (TGA) following vaccination.
01/03/2010